Previous studies and meta-analyses have reported inconsistent effects of BRCA1 and BRCA2 mutations on the outcomes of early breast cancer with better, worse, and similar outcomes for patients with a BRCA1 or BRCA2 mutation compared with patients with sporadic breast cancer. Here, BRCA2 is linked to breast cancer.